The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Pfizer Inc

NYSE: PFE
Last

(U.S.) $29.36

Today's change+0.23 +0.79%
Updated February 12 4:01 PM EST. Delayed by at least 15 minutes.
 

Pfizer Inc

NYSE: PFE
Last

(U.S.) $29.36

Today's change+0.23 +0.79%
Updated February 12 4:01 PM EST. Delayed by at least 15 minutes.

Pfizer Inc up (U.S.)$0.23

Pfizer Inc closed up Friday by (U.S.)$0.23 or 0.79% to (U.S.)$29.36. Over the last five days, shares have gained 1.14%, but sit 3.93% above the 52-week low. Shares have underperformed the S&P 500 by 5.09% during the last year.

Key company metrics

  • Open(U.S.) $29.25
  • Previous close(U.S.) $29.13
  • High(U.S.) $29.38
  • Low(U.S.) $28.98
  • Bid / Ask-- / --
  • YTD % change-9.05%
  • Volume32,543,171
  • Average volume (10-day)46,771,853
  • Average volume (1-month)38,652,288
  • Average volume (3-month)36,923,155
  • 52-week range(U.S.) $28.25 to (U.S.) $36.46
  • Beta0.89
  • Trailing P/E23.72×
  • P/E 1 year forward12.71×
  • Forward PEG2.34×
  • Indicated annual dividend(U.S.) $1.20
  • Dividend yield4.09%
  • Trailing EPS(U.S.) $1.24
Updated February 12 4:01 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+15.89%

Based on its net profit margin of 15.89%, Pfizer Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.43%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 27, 201509/27/2015Jun 28, 201506/28/2015Mar 29, 201503/29/2015
Revenue14,04712,08711,85310,864
Total other revenue--------
Total revenue14,04712,08711,85310,864
Gross profit10,6749,8809,6909,035
Total cost of revenue3,3732,2072,1631,829
Total operating expense12,6159,2188,0997,701
Selling / general / administrative5,0483,2703,3863,104
Research & development2,3481,7221,7341,885
Depreciation / amortization980937872940
Interest expense (income), net operating--------
Unusual expense (income)7721,286290170
Other operating expenses, total94-204-346-227
Operating income1,4322,8693,7543,163
Interest income (expense), net non-operating-335-278-278-309
Gain (loss) on sale of assets13519175
Other--------
Income before tax4312,6973,5393,082
Income after tax6192,1302,6342,376
Income tax, total-188567905706
Net income6132,1292,6262,375
Total adjustments to net income0100
Net income before extra. items6162,1212,6252,370
Minority interest-3-9-9-6
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items6162,1222,6252,370
Inc. avail. to common incl. extra. items6132,1302,6262,375
Diluted net income6132,1302,6262,375
Dilution adjustment0000
Diluted weighted average shares6,2496,2436,2436,292
Diluted EPS excluding extraordinary itemsvalue per share0.100.340.420.38
Dividends per sharevalue per share0.280.280.280.28
Diluted normalized EPSvalue per share0.180.510.460.37